CONTENT NOTE: Per client guidance, radiology-based cancer investigations are framed as ‘as recommended by your doctor’. This article focuses on blood-based tumour markers only. No claim is made that these tests diagnose cancer – they flag elevated markers requiring further clinical investigation.
Introduction
Cancer marker tests – also called tumour markers – are substances produced by cancer cells or by the body in response to cancer. Measured through a blood test, they can in some cases indicate whether cancer-related activity is occurring.
It is important to be clear about what these tests can and cannot do. A raised marker does not diagnose cancer – it means further investigation by a doctor is needed. A normal marker does not rule out cancer entirely. These tests are most useful as part of a broader preventive approach, particularly for people with a family history of specific cancers or known risk factors.
CEA – Carcinoembryonic Antigen
Normal range: below 2.5 ng/mL (non-smokers); up to 5.0 ng/mL for smokers. Source: PMC British Journal of Cancer, 2015.
CEA is associated with cancers of the colon, lung, pancreas, stomach, and breast. Non-cancerous conditions including cirrhosis and inflammatory bowel disease can also elevate CEA. A raised result requires clinical evaluation – it is not a standalone diagnostic.
CA-125 – Cancer Antigen 125
Normal range: below 35 U/mL in the healthy general population. Source: PMC diagnostic role of tumour markers study, 2012.
CA-125 is most closely associated with ovarian cancer. It is also elevated in endometriosis, uterine fibroids, menstruation, and some benign conditions. Elevated CA-125 in a postmenopausal woman is considered more clinically significant. It is not used as a standalone screening test in the general population – interpretation requires clinical context.
PSA – Prostate-Specific Antigen (Men Only)
Normal: below 4.0 ng/mL. Borderline: 4.0–10.0 ng/mL (further evaluation required). Above 10.0 ng/mL carries higher prostate cancer risk – though benign prostate enlargement also raises PSA.
PSA is prostate-specific but not cancer-specific. Benign prostatic hyperplasia (BPH) and prostatitis both elevate PSA. Results are always discussed with a urologist. PSA testing is generally recommended for men above 50, or above 40 with a family history of prostate cancer.
AFP – Alpha-Fetoprotein
Normal in non-pregnant adults: below 10 ng/mL. Source: standard clinical reference.
AFP is associated with liver cancer (hepatocellular carcinoma) and certain germ cell tumours. It is especially relevant for individuals with cirrhosis, chronic hepatitis B or C, or known fatty liver disease. Elevated AFP with known liver disease warrants imaging follow-up.
Who Should Discuss Cancer Marker Testing?
- Adults above 40 with a family history of any cancer
- Individuals with known risk factors: obesity, chronic liver disease, smoking history
- As part of an advanced preventive health package
- Anyone with unexplained weight loss, persistent fatigue, or changes in bowel or urinary habits – speak with a doctor
All cancer marker test results should be reviewed with a qualified doctor, who can assess them alongside your medical history, symptoms, and other investigations.
Frequently Asked Questions
Q1. What are cancer marker tests and what do they detect?
Cancer marker tests (tumour markers) are blood tests that measure substances produced by cancer cells or by the body in response to certain cancers. Commonly tested markers include CEA (associated with colon, lung, and pancreatic cancers), CA-125 (associated with ovarian cancer), PSA (prostate cancer risk in men), and AFP (liver cancer risk). A raised marker indicates further investigation is needed – it does not diagnose cancer.
Q2. What is the normal range for CEA?
The normal CEA level for non-smokers is below 2.5 ng/mL. For smokers, values up to 5.0 ng/mL may be considered acceptable. CEA can be elevated in non-cancerous conditions including cirrhosis, inflammatory bowel disease, and chronic lung disease. An elevated CEA result requires clinical review by a doctor.
Q3. What is the normal CA-125 level?
The upper limit of normal for CA-125 in the healthy general population is 35 U/mL. CA-125 is most associated with ovarian cancer but is also elevated in endometriosis, uterine fibroids, and menstruation. Elevated CA-125 in a postmenopausal woman has greater clinical significance and should be evaluated by a gynaecologist.
Q4. What is the normal PSA level?
PSA below 4.0 ng/mL is generally considered normal. PSA between 4.0 and 10.0 ng/mL is borderline and warrants further investigation, including discussion with a urologist. PSA above 10.0 ng/mL is associated with higher prostate cancer risk, though benign prostate enlargement also elevates PSA – only a urologist can interpret the result in clinical context.
Q5. Which health checkup packages include cancer marker tests?
FITTR Labs includes cancer marker testing in its advanced preventive health packages. For the specific package that includes your required markers, call +91 7804000800 or visit fittr.com/labs/. Cancer marker tests are available with home blood sample collection across all 10 FITTR Labs locations in Pune.
Q6. Do cancer marker tests confirm whether I have cancer?
No. Cancer marker tests do not diagnose cancer. A raised result indicates that further investigation – imaging, biopsy, specialist consultation – may be warranted. Equally, normal marker levels do not completely rule out cancer. These tests are most valuable as part of a broader preventive screening approach, interpreted by a qualified doctor alongside your complete clinical picture.
